1-3 of 3
Ryan Hare
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Othman S. Akhtar, MD, Kris Attwood, PhD MS, Ian Lund, PA-C, Ryan Hare, PharmD, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5567.
https://doi.org/10.1182/blood-2018-99-112334
Published: 2018
Journal Articles

Disease Progression on Ibrutinib Therapy Is Associated with a Poor Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Managed in Standard Clinical Practice

Othman S. Akhtar, MD, Pallawi Torka, MD, Seema A. Bhat, MD, Ryan Hare, Sheila N. J. Sait, PhD, AnneMarie W. Block, PhD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5350.
https://doi.org/10.1182/blood.V130.Suppl_1.5350.5350
Published: 2017
Journal Articles

Therapeutic Effects of Metformin in Follicular Lymphoma (FL) Treated with Rituximab in Combination with Bendamustine

Angel Mier Hicks, MD, Anil Singh, MD, Juan Gu, MD PhD, Ryan Hare, Pallawi Torka, MD, Austin Miller, PhD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5152.
https://doi.org/10.1182/blood.V130.Suppl_1.5152.5152
Published: 2017